| Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies (NCT05240690) | Zhou Fuxiang | 2022-02-07 |
| Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer (NCT05088889) | Sheba Medical Center | 2022-01-25 |
| SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells (NCT04150042) | General Oncology, Inc. | 2021-01-13 |
| Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer (NCT04377048) | National Taiwan University Hospital | 2020-07-01 |
| Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites (NCT04267575) | Jerome Canady, M.D. | 2019-07-30 |
| Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer (NCT03825289) | University of Utah | 2019-01-30 |
| Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors (NCT03682289) | Rahul Aggarwal | 2019-01-17 |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer (NCT03412799) | Panbela Therapeutics, Inc. | 2018-06-04 |
| TAS102 in Combination With NAL-IRI in Advanced GI Cancers (NCT03368963) | Emory University | 2018-01-30 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer (NCT03095781) | Emory University | 2017-07-07 |
| APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery (NCT03087591) | Wake Forest University Health Sciences | 2017-04-28 |
| Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery (NCT02896907) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2016-10-18 |
| BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer (NCT02620865) | Barbara Ann Karmanos Cancer Institute | 2015-12-01 |
| Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896) | University of Southern California | 2015-09-03 |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer (NCT02048943) | Roswell Park Cancer Institute | 2015-03-01 |
| Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer (NCT02227940) | Roswell Park Cancer Institute | 2015-01-08 |
| Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer (NCT01927393) | City of Hope Medical Center | 2014-12-01 |
| APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT02166255) | Wake Forest University Health Sciences | 2014-12-01 |
| Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer (NCT02333188) | University of Chicago | 2014-12-01 |
| Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer (NCT02307539) | City of Hope Medical Center | 2014-11-01 |
| Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer (NCT02178436) | Mohammed Najeeb Al Hallak | 2014-10-31 |
| Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung (NCT01741597) | City of Hope Medical Center | 2014-07-01 |
| Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy (NCT02414100) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-12-12 |
| Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer (NCT02050178) | OncoMed Pharmaceuticals, Inc. | 2013-11-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer (NCT02005315) | OncoMed Pharmaceuticals, Inc. | 2013-09-01 |
| Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer (NCT01924260) | Edward Kim | 2013-08-09 |
| CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT01839981) | Wake Forest University Health Sciences | 2013-07-01 |
| Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA (NCT01893801) | Pancreatic Cancer Research Team | 2013-05-01 |
| Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer (NCT01893294) | Mayo Clinic | 2013-04-01 |
| CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer (NCT01835041) | Wake Forest University Health Sciences | 2013-04-01 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer (NCT01666730) | Case Comprehensive Cancer Center | 2013-02-21 |
| Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer (NCT01851174) | Western Regional Medical Center | 2013-02-01 |
| Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors (NCT01525082) | Shaheen Shagufta | 2012-12-01 |
| A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer (NCT01647828) | OncoMed Pharmaceuticals, Inc. | 2012-10-01 |
| Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy (NCT01658943) | National Cancer Institute (NCI) | 2012-08-01 |
| Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery (NCT01473940) | Northwestern University | 2012-06-11 |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers (NCT01497392) | Roswell Park Cancer Institute | 2012-03-29 |
| VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer (NCT01486329) | Vaximm GmbH | 2011-12-01 |
| Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer (NCT01488552) | Pancreatic Cancer Research Team | 2011-11-01 |
| Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer (NCT01191684) | City of Hope Medical Center | 2011-10-01 |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca (NCT01555489) | Thomas Jefferson University | 2011-10-01 |
| Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer (NCT01453153) | Halozyme Therapeutics | 2011-09-01 |
| Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer (NCT01282333) | National Cancer Institute (NCI) | 2011-01-01 |
| PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer (NCT01227018) | Vanderbilt-Ingram Cancer Center | 2010-12-01 |
| Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer (NCT01280058) | National Cancer Institute (NCI) | 2010-12-01 |
| Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT01222689) | National Cancer Institute (NCI) | 2010-11-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer (NCT01232829) | National Cancer Institute (NCI) | 2010-10-01 |
| Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer (NCT01195415) | National Cancer Institute (NCI) | 2010-06-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride (NCT00981162) | Roswell Park Cancer Institute | 2009-08-01 |
| Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer (NCT00735917) | National Cancer Institute (NCI) | 2008-10-01 |
| Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer (NCT00577889) | National Cancer Institute (NCI) | 2008-03-01 |
| S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery (NCT00617708) | National Cancer Institute (NCI) | 2008-03-01 |
| Dasatinib in Treating Patients With Metastatic Pancreatic Cancer (NCT00474812) | National Cancer Institute (NCI) | 2007-05-01 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine (NCT00397787) | National Cancer Institute (NCI) | 2006-11-01 |
| Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer (NCT01534637) | Wake Forest University Health Sciences | 2006-08-01 |
| Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients (NCT00383760) | National Cancer Institute (NCI) | 2006-08-01 |
| Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer (NCT00331682) | National Cancer Institute (NCI) | 2006-03-01 |
| Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348) | National Cancer Institute (NCI) | 2005-01-01 |
| Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer (NCT00114244) | National Cancer Institute (NCI) | 2004-12-01 |
| Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas (NCT00085371) | National Cancer Institute (NCI) | 2004-07-01 |
| Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer (NCT00091026) | National Cancer Institute (NCI) | 2004-07-01 |
| Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT00088894) | National Cancer Institute (NCI) | 2004-06-01 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191) | National Cancer Institute (NCI) | 2004-05-01 |
| CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT00075647) | National Cancer Institute (NCI) | 2003-12-01 |
| Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer (NCT00052689) | National Cancer Institute (NCI) | 2002-12-01 |
| Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer (NCT00047307) | National Cancer Institute (NCI) | 2002-08-01 |
| UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer (NCT00039403) | National Cancer Institute (NCI) | 2002-04-01 |
| Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer (NCT00031694) | National Cancer Institute (NCI) | 2002-03-01 |
| Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer (NCT00028834) | National Cancer Institute (NCI) | 2002-02-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496) | National Cancer Institute (NCI) | 2001-11-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer (NCT00003531) | Burzynski Research Institute | 1996-04-10 |
| Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer (NCT02575508) | Roswell Park Cancer Institute | |